Immunotherapy in patients with oral malignant disease.
D000912:Antibodies, Neoplasm / Q000096:biosynthesis; D000951:Antigens, Neoplasm / Q000008:administration & dosage; D001500:BCG Vaccine / Q000627:therapeutic use; D003429:Cross Reactions; D006258:Head and Neck Neoplasms / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007116:Immunization, Passive; D007167:Immunotherapy; D009062:Mouth Neoplasms / Q000276:immunology / Q000628:therapy*
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D001500:BCG Vaccine